Dratwa M - Search Results

1

Hemodynamics of patients with renal failure treated with recombinant human erythropoietin.

Verbeelen D, Bossuyt A, Smitz J, Herman A, Dratwa M, Jonckheer MH. Verbeelen D, et al. Among authors: dratwa m. Clin Nephrol. 1989 Jan;31(1):6-11. Clin Nephrol. 1989. PMID: 2914412

2

Acceptability of rilmenidine and long-term surveillance of plasma concentrations in hypertensive patients with renal insufficiency.

Lins RL, Daelemans R, Dratwa M, Verbeelen D, Sennesael J, Brisgand B, Lameire N. Lins RL, et al. Among authors: dratwa m. Am J Med. 1989 Sep 18;87(3C):41S-45S. doi: 10.1016/0002-9343(89)90505-6. Am J Med. 1989. PMID: 2782326

3

Improvement of anemia with deferoxamine in hemodialysis patients with aluminum-induced bone disease.

Tielemans C, Collart F, Wens R, Smeyers-Verbeeke J, van Hooff I, Dratwa M, Verbeelen D. Tielemans C, et al. Among authors: dratwa m. Clin Nephrol. 1985 Nov;24(5):237-41. Clin Nephrol. 1985. PMID: 4075595

4

Treatment of gram-negative peritonitis with aztreonam in patients undergoing continuous ambulatory peritoneal dialysis.

Dratwa M, Glupczynski Y, Lameire N, Matthys D, Verschraegen G, Vaneechoutte M, Boelaert J, Schurgers M, Van Landuyt H, Verbeelen D, et al. Dratwa M, et al. Rev Infect Dis. 1991 May-Jun;13 Suppl 7:S645-7. doi: 10.1093/clinids/13.supplement_7.s645. Rev Infect Dis. 1991. PMID: 2068475 Clinical Trial.

5

Responsiveness to recombinant erythropoietin therapy in end-stage renal disease. An analysis of the predictive value of several biological measurements, including circulating erythroid progenitors.

Corazza F, Bergmann P, Dratwa M, Guns M, Fondu P. Corazza F, et al. Among authors: dratwa m. Nephrol Dial Transplant. 1992;7(4):311-7. doi: 10.1093/oxfordjournals.ndt.a092134. Nephrol Dial Transplant. 1992. PMID: 1317521

6

Effects of recombinant human erythropoietin on T lymphocyte subsets in hemodialysis patients.

Collart FE, Dratwa M, Wittek M, Wens R. Collart FE, et al. Among authors: dratwa m. ASAIO Trans. 1990 Jul-Sep;36(3):M219-23. ASAIO Trans. 1990. PMID: 2147556 Clinical Trial.

7

Red blood cells indices and aluminium toxicity in haemodialysis patients.

Tielemans C, Kalima L, Collart F, Wens R, Smeyers-Verbeke J, Verbeelen D, Dratwa M. Tielemans C, et al. Among authors: dratwa m. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:395-8. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985. PMID: 3991530

8

Anaemia and aluminium chelation therapy in dialysis patients.

Tielemans C, Collart F, Wens R, Smeyers-Verbeeke J, Van Hooff I, Dratwa M, Verbeelen D. Tielemans C, et al. Among authors: dratwa m. Lancet. 1988 Jul 23;2(8604):220. doi: 10.1016/s0140-6736(88)92323-9. Lancet. 1988. PMID: 2899690 No abstract available.

9

Performance of an immunoradiometric assay of erythropoietin and results for specimens from anemic and polycythemic patients.

Andre M, Ferster A, Toppet M, Fondu P, Dratwa M, Bergmann P. Andre M, et al. Among authors: dratwa m. Clin Chem. 1992 May;38(5):758-63. Clin Chem. 1992. PMID: 1582031

10

Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study.

Lins RL, Matthys KE, Billiouw JM, Dratwa M, Dupont P, Lameire NH, Peeters PC, Stolear JC, Tielemans C, Maes B, Verpooten GA, Ducobu J, Carpentier YA. Lins RL, et al. Among authors: dratwa m. Clin Nephrol. 2004 Oct;62(4):287-94. doi: 10.5414/cnp62287. Clin Nephrol. 2004. PMID: 15524059 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters